Showing results (1951-1960 of 6,791) with videos related to
Sort By:
Pageof 680
The Journal of Antibiotics|May 11, 2021
A short synthetic peptide, based on LyeTx I from Lycosa erythrognatha venom, shows potential to treat pneumonia caused by carbapenem-resistant Acinetobacter baumannii without detectable resistanceWilliam Gustavo Lima, Júlio César Moreira Brito, Maria Elena de Lima, et al.The Journal of Antibiotics|April 1, 1979
Active groups of bicyclomycin and the reaction with thiolsA Someya, M Iseki, N TanakaThe Journal of Antibiotics|September 1, 1981
Inhibition of lymph node metastasis of P388 leukemia by bestatin in miceT Tsuruo, K Naganuma, H Iida, et al.The Journal of Antibiotics|November 1, 1981
Fredericamycin A, a new antitumor antibiotic. II. Biological propertiesD J Warnick-Pickle, K M Byrne, R C Pandey, et al.The Journal of Antibiotics|November 1, 1981
Aminoglycoside antibiotics. XIV. Synthesis and activity of 6-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-and 5-O-(beta-D-ribofuranosyl)apramycinsY Abe, S Nakagawa, T Naito, et al.The Journal of Antibiotics|August 1, 1981
Antibacterial activity of DL 473, a new semisynthetic rifamycin derivativeV Arioli, M Berti, G Carniti, et al.The Journal of Antibiotics|August 1, 1981
Candiplanecin, a new antibiotic from Ampullariella regularis subsp. mannitophila subsp. nov. II. Isolation, physico-chemical characterization and biological activitiesY Itoh, A Torikata, C Katayama, et al.The Journal of Antibiotics|August 1, 1981
New rifamycins produced by a recombinant strain of Nocardia mediterraneiT Schupp, P Traxler, J A AudenThe Journal of Antibiotics|August 1, 1981
3-Hydroxyrifamycin S and further novel ansamycins from a recombinant strain R-21 of Nocardia mediterraneiP Traxler, T Schupp, H Fuhrer, et al.The Journal of Antibiotics|June 1, 1979
Rapamycin (AY-22,989), a new antifungal antibiotic. IV. Mechanism of actionK Singh, S Sun, C VézinaPageof 680